ZGEN now has unfortunately become a tax loss stock for this year. Irrespective of the promise that will materialize on Jan 17, I suspect many will shoot first and ask questions later. The stock is already trading down about 10% in after market but I suspect there will be more blood tomorrow.
IMO, Below $10 ZGEN is a strong buy but until then it is a risky stock for the remainder of 2007...
Amusing: one of the analysts on ZGEN’s CC asked why ZGEN had not submitted the fill/finish data from Raytheon earlier in the FDA’s review of the BLA so that there would not have been a delay for the FDA to have time to examine these data.
Quiz: What company should the analyst have been asking about instead of Raytheon?
Market Data 
Markets 
AI
